gentian violet has been researched along with Head and Neck Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhonde, R; Joshi, K; Kheur, S; Kumbhar, GM; Ladke, VS; Raut, C | 1 |
| Bagulkar, B; Bhat, A; Jaiswal, S; Kapoor, P; Motiwale, G; Motiwale, T; Vikey, A | 1 |
| Gaffney, C; Gollins, S; Slade, S; Swindell, R | 1 |
| Donato, NJ; Johnson, FM; Newman, RA; Yang, P | 1 |
| Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
1 trial(s) available for gentian violet and Head and Neck Neoplasms
| Article | Year |
|---|---|
RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation.
Topics: Aged; Anti-Infective Agents, Local; Bandages, Hydrocolloid; Breast Neoplasms; Clinical Nursing Research; Female; Gentian Violet; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nursing Assessment; Proportional Hazards Models; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Skin Care; Statistics, Nonparametric; Time Factors; Treatment Outcome; Wound Healing | 2008 |
4 other study(ies) available for gentian violet and Head and Neck Neoplasms
| Article | Year |
|---|---|
Isolation, Culture and Morphological Assessment of Primary Cell Lines from Human Primary Oral Squamous Cell Carcinoma Using Explant Technique.
Topics: Carcinoma, Squamous Cell; Cell Line; Coloring Agents; Eosine Yellowish-(YS); Gentian Violet; Head and Neck Neoplasms; Hematoxylin; Humans; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2023 |
Evaluation of efficacy of 1% Crystal Violet & Nuclear Fast Red stain compared to Haematoxyline & Eosin stain for assessing mitotic figures in oral premalignant and malignant lesions.
Topics: Adolescent; Adult; Aged; Anthraquinones; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Coloring Agents; Eosine Yellowish-(YS); Female; Gentian Violet; Head and Neck Neoplasms; Hematoxylin; Humans; Male; Metaphase; Middle Aged; Mitosis; Mitotic Index; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Predictive Value of Tests; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Staining and Labeling; Young Adult | 2016 |
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
Topics: Anti-Infective Agents, Local; Antineoplastic Agents; Arachidonic Acid; Benzamides; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Activation; ErbB Receptors; Gentian Violet; Head and Neck Neoplasms; Humans; Imatinib Mesylate; MAP Kinase Kinase 1; Membrane Proteins; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Time Factors | 2004 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |